A direct role for secretory phospholipase A2 and lysophosphatidylcholine in the mediation of LPS-induced gastric injury

Shock

Volumn 33, Issue 6, 2010, Pages 634-638

  Dial, Elizabeth J ^a   Tran, Duy M ^a   Romero, Jimmy J ^a   Zayat, Mayssa ^a   Lichtenberger, Lenard M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Endotoxin; Epithelium; Gastric mucosa; Hydrophobicity; Phosphatidylcholine

Indexed keywords

LIPOPOLYSACCHARIDE; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; SECRETORY PHOSPHOLIPASE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTACT ANGLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; HYDROPHOBICITY; INCUBATION TIME; INFLAMMATION; MALE; MEMBRANE DAMAGE; NONHUMAN; PERMEABILITY BARRIER; RAT; STOMACH CONTENT; STOMACH EPITHELIUM; STOMACH INJURY; STOMACH JUICE; STOMACH MUCOSA;

ANIMALS; BEE VENOMS; ENDOTOXEMIA; EPITHELIAL CELLS; GASTRIC MUCOSA; HUMANS; HYDROPHOBICITY; LIPOPOLYSACCHARIDES; LYSOPHOSPHATIDYLCHOLINES; MALE; PHOSPHOLIPASES A2, SECRETORY; RATS; RATS, SPRAGUE-DAWLEY; SNAKE VENOMS; TUMOR CELLS, CULTURED;

EID: 77952398305     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181cb9266     Document Type: Article

References (41)

1. Beutler B, Cerami A: Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem 57:505-518, 1988.
2. Remick DG, Strieter RM, Eskandari MK, Nguyen DT, Genord MA, Raiford CL, Kunkel SL: Role of tumor necrosis factor-! in lipopolysaccharide-induced pathologic alterations. Am J Pathol 136:49-60, 1990.
3. Martich GD, Danner RI, Ceska M, Suffredini AF: Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of anti-inflammatory agents. J Exp Med 173:1021-1024, 1991.
4. Mercer DW, Castaneda AA, Denning JW, Chang L, Russell DH: Effects of endotoxin on gastric injury from luminal irritants in rats: potential roles of nitric oxide. Am J Physiol 275:G449-G459, 1998.
5. Helmer KS, West SD, Vilela R, Chang L, Cui Y, Kone BC, Mercer DW: Lipopolysaccharide-induced changes in rat gastric H/K-ATPase expression. Ann Surg 239:501-509, 2004.
6. Dial EJ, Romero JJ, Villa X, Mercer DW, Lichtenberger LM: Lipopolysac-charide-induced gastrointestinal injury in rats: role of surface hydrophobicity and bile salts. Shock 17:77-80, 2002.
7. 2. Shock 30:206-211, 2008.
8. Hills BA, Butler BD, Lichtenberger LM: Gastric mucosal barrier: hydrophobic lining to the lumen of the stomach. Am J Physiol 244:G561-G568, 1983.
9. Goddard PJ, Kao YJ, Lichtenberger LM: Luminal surface hydrophobicity of canine gastric mucosa is dependent on a surface mucous gel. Gastroenterology 98:361-370, 1990.
10. Hills BA, Kirkwood CA: Gastric mucosal barrier to hydrogen ions imparted by gastric surfactant in vitro. Gut 33:1039-1041, 1992.
11. Spychal RT, Goggin PM, Marrero JM, Saverymuttu SH, Yu CW, Corbishley CM, Maxwell JD, Northfield TC: Surface hydrophobicity of gastric mucosa in peptic ulcer disease. Gastroenterology 98:1250-1254, 1990.
12. Lichtenberger LM, Dial EJ, Ottlecz A, Romero JJ, Lechago J, Fox JG: Attenuation of hydrophobic phospholipid barrier is an early event in Helicobacter felisYinduced gastritis in mice. Dig Dis Sci 44:108-115, 1999.
13. Tatsumi Y, Lichtenberger LM: Molecular association of trinitrobenzenesul-fonic acid and surface phospholipids in the development of colitis in rats. Gastroenterology 110:780-789, 1996.
14. Ehehalt R, Wagenblast J, Erben G, Lehmann W-D, Hinz U, Merle U, Stremmel W: Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoelectrospray-tandem mass spectrometry. Scand J Gastroenterol 39:737-742, 2004.
15. Lichtenberger LM, Wang Z-M, Romero JJ, Ulloa C, Perez JC, Giraud M-N, Barreto JC: Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nat Med 1:154-158, 1995.
16. Lugea A, Antolin M, Mourelle M, Guarner F, Malagelada J-R: Deranged hydrophobic barrier of the rat gastroduodenal mucosa after parenteral non-steroidal anti-inflammatory drugs. Gastroenterology 112:1931-1939, 1997.
17. Lichtenberger LM, Romero JJ, Kao Y-CJ, Dial EJ: Gastric protective activity of mixtures of saturated polar and neutral lipids in rats. Gastroenterology 99:311-326, 1990.
18. Barranco SC, Townsend CM Jr, Casartelli C, Macik BG, Burger NL, Boerwinkle WR, Gourley WK: Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res 43:1703-1709, 1983.
19. Dial EJ, Doyen JR, Lichtenberger LM: Phosphatidylcholine-associated non-steroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro. Cancer Chemother Pharmacol 57:295-300, 2006.
20. Quaroni A, Wands J, Trelstad RL, Isselbacher KJ: Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biol 80:248-265, 1979.
21. Kivilaakso E, Ehnholm C, Kalima TV, Lempinin M: Duodenogastric reflux of lysolecithin in the pathogenesis of experimental porcine stress ulceration. Surgery 79:65-69, 1976.
22. Kivilaakso E, Fromm D, Silen W: Effects of lysolecithin on isolated gastric mucosa. Surgery 84:616-621, 1978.
23. Maksem J, Jacobson N, Neiderhiser DH: Lysophosphatidylcholine-induced gastric injury and ulceration in the guinea pig. Am J Pathol 115:288-295, 1984.
24. Karlqvist P-A, Franzen L, Sjodahl R, Tagesson C: A study of the permeability of rat stomach to larger molecules. Influence of lysophosphatidylcholine. Acta Chir Scand 152:279-284, 1986. (Pubitemid 16055710)
25. Lichtenberger LM, Dial EJ, Ottlecz A, Romero JJ, Lechago J, Fox JG: Attenuation of hydrophobic phospholipid barrier is an early event in Helicobacter felisYinduced gastritis in mice. Dig Dis Sci 44:108-115, 1999.
26. Goddard PJ, Hills BA, Lichtenberger LM: Does aspirin damage canine gastric mucosa by reducing its surface hydrophobicity? Am J Physiol 252: G421-G430, 1987.
27. Lichtenberger LM, Romero JJ, Kao YC-J, Dial EJ: Gastric protective activity of mixtures of saturated polar and neutral lipids in rats. Gastroenterology 99:311-326, 1990.
28. Giraud M-N, Motta C, Romero JJ, Bommelaer G, Lichtenberger LM: Interaction of indomethacin and naproxen with gastric surface-active phos-pholipids: a possible mechanism for the gastric toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs). Biochem Pharmacol 57:247-254, 1999.
29. Spychal RT, Goggin PM, Marrero JM, Saverymuttu SH, Yu CW, Corbishley MC, Maxwell JD, Northfield TC: Surface hydrophobicity of gastric mucosa in peptic ulcer disease. Relationship to gastritis and Campylobacter pylori infection. Gastroenterology 98:1250-1254, 1990.
30. Goggin PM, Marrero JM, Spychal RT, Jackson PA, Corbishley CM, Northfield TC: Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication. Gastroenterology 103:1486-1490, 1992.
31. Dial EJ, Rooijakkers SHM, Darling RL, Romero JJ, Lichtenberger LM: Role of phosphatidylcholine saturation in preventing bile salt toxicity to gastrointestinal epithelia and membranes. J Gastroenterol Hepatol 23:430-436, 2007.
32. 2 in calcium-ionophoreYmediated injury to rat gastric mucosal cells. Dig Dis Sci 44: 494-502, 1999.
33. 2 in Swiss 3T3 cells via specific binding site. J Biol Chem 266:19139-19141, 1991.
34. 2 in the rat. J Biol Chem 267:6414-6420, 1992.
35. 2 production in rat mesangial cells by receptor binding reaction. J Biochem 117:420-424, 1995.
36. 2 via its high affinity receptor stimulates extracellular matrix invasion by normal and cancer cells. J Biol Chem 272:2346-2353, 1997.
37. 2 via its receptor regulates the expression of key enzymes of phospholipid an sphingolipid metabolism. FASEB J 15:1834-1836, 2001.
38. Dial EJ, Zayat M, Lopez-Storey M, Tran D, Lichtenberger LM: Oral phos-phatidylcholine preserves the gastrointestinal mucosal barrier during LPS-induced inflammation. Shock 30:729-733, 2008.
39. Dial E, Lopez-Storey M, Adams S, Lichtenberger L, Gonzalez E, McKinley B, Moore F, Mercer D: A report on associations among gastric pH, bleeding, duodenogastric reflux, and outcomes after trauma. J Trauma 64:105-110, 2008.
40. Schindlbeck NE, Lippert M, Heinrich C, Muller-Lissner SA: Intragastric bile acid concentrations in critically ill artificially ventilated patients. Am J Gas-troenterol 84:624-628, 1989.
41. Wilmer A, Tack J, Frans E, Dits H, Vanderschueren S, Givers A, Bobbaers H: Duodenogastroesophageal reflux and esophageal mucosal injury in mechanically ventilated patients. Gastroenterology 116:1293-1299, 1999.